Home

JANE LEBKOWSKI

CIK 1187035 · Chief Scientific Officer · last filed 2017-06-07

JANE LEBKOWSKI is a Chief Scientific Officer who has filed 23 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing shows the insider had shares withheld for taxes covering $22.4K of AST.WS on Jun 7, 2017. Across all open-market trades the lifetime net is −$421.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $854.5K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$854.5K

Companies

3

Total Filings

23

Lifetime Open-Market Net

-$421.1K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Asterias Biotherapeutics, Inc. (AST.WS) Delisted Chief Scientific Officer 102,991 — — $0 4 2017-06-07
Asterias Biotherapeutics, Inc. (AST) Delisted President of R&D 27,007 — — -$29.5K 5 2016-03-29
GERN SVP, Chief Scientific Officer 589,331 $1.45 $854.5K -$391.6K 13 2011-06-16

Recent Filings

23 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-06-07 Asterias Biotherapeutics, Inc. (AST.WS) Delisted Tax (F) −7,015 -$22.4K EDGAR
2017-04-03 Asterias Biotherapeutics, Inc. (AST.WS) Delisted Grant (A) +92,670 $0 EDGAR
2017-01-11 Asterias Biotherapeutics, Inc. (AST.WS) Delisted Tax (F) −2,537 $0 EDGAR
2016-10-11 Asterias Biotherapeutics, Inc. (AST.WS) Delisted Tax (F) −2,537 $0 EDGAR
2016-03-29 Asterias Biotherapeutics, Inc. (AST) Delisted Grant (A) +27,007 $0 EDGAR
2016-03-01 Asterias Biotherapeutics, Inc. (AST) Delisted Grant (A) — $0 EDGAR
2015-09-16 Asterias Biotherapeutics, Inc. (AST) Delisted Sell (S) −4,912 -$29.5K EDGAR
2015-07-02 Asterias Biotherapeutics, Inc. (AST) Delisted Tax (F) −2,844 -$13.1K EDGAR
2015-02-18 Asterias Biotherapeutics, Inc. (AST) Delisted Grant (A) — $0 EDGAR
2014-08-20 — Other (J) +476 $0
Showing 1–10 of 23
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.